On this day last year, the SNAP trial started recruitment. 12 months on, more than 450 participants have joined the study, already making it the second largest clinical trial for Staphylococcus aureus bloodstream infections in the world.
We are pleased to share the November issue of the SNAP Trial Global Newsletter.
The SNAP trial includes all age groups because people of all ages.
A summary of how Staphylococcus aureus and penicillin have been instrumental in both the success and failure of one another since they met. Carly Botheras (PhD Candidate, Geelong Centre for Emerging Infectious Diseases, Barwon Health)
